<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 48-year-old female with severe <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> refractory to conventional therapy was referred to our facility for management </plain></SENT>
<SENT sid="1" pm="."><plain>The patient showed extensive <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> since the age of 20 years and had failed therapy with <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> agents and <z:chebi fb="2" ids="2948">azathioprine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The disease remained active despite treatment with steroids and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical and endoscopic parameters were consistent with severe disease </plain></SENT>
<SENT sid="4" pm="."><plain>Infectious precipitants were ruled out </plain></SENT>
<SENT sid="5" pm="."><plain>Given the severity of the disease and in order to avoid a colectomy, we started the patient on infliximab therapy </plain></SENT>
<SENT sid="6" pm="."><plain>A dramatic clinical and endoscopic response was observed and she remained in remission at the end of a 1-year follow-up period </plain></SENT>
<SENT sid="7" pm="."><plain>We discuss findings in the literature regarding the use of infliximab therapy in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> who have failed steroids and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
</text></document>